Sun, 13 Dec 2020 04:01:12 GMT
BioNTech looks for more vaccine production
BioNTech's CEO Ugur Sahin said that the biggest hurdle facing Pfizer-BioNTech now that the US FDA has authorized the vaccine for emergency use would be to scale up production to meet the huge demand.